Clemedi
Clemedi provides clinicians with faster, actionable antibiotic resistance information to enable earlier, targeted therapy for infectious disease patients. The company develops in vitro diagnostic tests that combine next-generation sequencing and machine learning models to detect and predict antimicrobial resistance profiles. Its products are intended for use by clinical laboratories and healthcare providers as diagnostic tools to support prescribing decisions. Clemedi operates in the infectious disease diagnostics category and targets hospital and laboratory customers to reduce inappropriate antibiotic use and improve patient outcomes.
Clemedi
Clemedi provides clinicians with faster, actionable antibiotic resistance information to enable earlier, targeted therapy for infectious disease patients. The company develops in vitro diagnostic tests that combine next-generation sequencing and machine learning models to detect and predict antimicrobial resistance profiles. Its products are intended for use by clinical laboratories and healthcare providers as diagnostic tools to support prescribing decisions. Clemedi operates in the infectious disease diagnostics category and targets hospital and laboratory customers to reduce inappropriate antibiotic use and improve patient outcomes.